Liquidity Agreement Monthly Update and Total Voting Rights

Paris, France and Camberley, UK – 1 November 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is

Visit Page

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers http://novacyt.com/wp-content/uploads/2019/10/NOVACYT_CP_Droits-de-vote_2019-Oct-2019.pdf

Visit Page

New molecular respiratory panel ready for the US market

Multiplex test identifies up to 37 respiratory pathogens Paris, France and Camberley, UK – 7 October 2019 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces the succesful development of a new molecular diagnostic multiplex test for respiratory infections, which is ready for launch in North America in time for

Visit Page